MUSTANG BIO, INC. Earnings Per Share (Basic)
MUSTANG BIO, INC. (MBIO) reported Earnings Per Share (Basic) of -$0.16 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- MUSTANG BIO, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.16.
- MUSTANG BIO, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.14.
- MUSTANG BIO, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.08.
- MUSTANG BIO, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.07.
- MUSTANG BIO, INC. earnings per share, basic for fiscal 2025 was -$0.39.
- MUSTANG BIO, INC. earnings per share, basic for fiscal 2024 was -$38.57.
- MUSTANG BIO, INC. earnings per share, basic for fiscal 2023 was -$299.95.
- MUSTANG BIO, INC. earnings per share, basic for fiscal 2022 was -$10.09.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.16 10-Q · filed 2026-08-05 | -$0.30 10-Q · filed 2026-08-05 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||||
| 2026-03-31 | -$0.14 10-Q · filed 2026-05-05 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-05-05 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-05-05 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||||
| 2025-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.39 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | -$0.07 10-Q · filed 2025-11-07 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.32 10-Q · filed 2025-11-07 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||||
| 2025-06-30 | -$0.19 10-Q · filed 2026-08-05 | -$0.27 10-Q · filed 2026-08-05 | -$0.71 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.51 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||||
| 2025-03-31 | -$0.05 10-Q · filed 2026-05-05 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-05-05 | -$1.63 derived: net income ÷ weighted average shares · filed 2026-05-05 | -$8.42 derived: net income ÷ weighted average shares · filed 2026-05-05 | ||||
| 2024-12-31 | -$0.90 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$2.65 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$14.23 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$38.57 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | -$1.96 10-Q · filed 2025-11-07 | -$0.04 10-Q · filed 2024-11-08 | -$16.46 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$32.18 10-Q · filed 2025-11-07 | -$0.62 10-Q · filed 2024-11-08 | $4.19 derived: net income ÷ weighted average shares · filed 2025-11-07 | ||
| 2024-06-30 | -$18.36 10-Q · filed 2025-08-08 | -$0.35 10-Q · filed 2024-08-13 | -$40.83 10-Q · filed 2025-08-08 | -$0.78 10-Q · filed 2024-08-13 | $2.86 derived: net income ÷ weighted average shares · filed 2025-08-08 | $8.62 derived: net income ÷ weighted average shares · filed 2025-08-08 | ||
| 2024-03-31 | -$24.81 10-Q · filed 2025-05-14 | -$0.46 10-Q · filed 2024-05-15 | $1.18 derived: net income ÷ weighted average shares · filed 2025-05-14 | $4.67 derived: net income ÷ weighted average shares · filed 2025-05-14 | $22.29 derived: net income ÷ weighted average shares · filed 2025-05-14 | |||
| 2023-12-31 | $0.36 derived: net income ÷ weighted average shares · filed 2025-03-28 | $2.40 derived: net income ÷ weighted average shares · filed 2025-03-28 | $14.14 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$299.95 10-K · filed 2025-03-28 | -$6.00 10-K · filed 2024-03-11 | |||
| 2023-09-30 | -$1.23 10-Q · filed 2024-11-08 | -$3.23 derived: net income ÷ weighted average shares · filed 2024-11-08 | -$5.29 10-Q · filed 2024-11-08 | -$7.75 derived: net income ÷ weighted average shares · filed 2024-11-08 | ||||
| 2023-06-30 | -$2.00 10-Q · filed 2024-08-13 | -$4.06 10-Q · filed 2024-08-13 | -$6.53 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$8.95 derived: net income ÷ weighted average shares · filed 2024-08-13 | ||||
| 2023-03-31 | -$2.06 10-Q · filed 2024-05-15 | -$4.54 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$6.96 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$9.45 derived: net income ÷ weighted average shares · filed 2024-05-15 | ||||
| 2022-12-31 | -$2.48 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$4.90 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$7.40 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$10.09 10-K · filed 2024-03-11 | -$0.75 10-K · filed 2023-03-30 | |||
| 2022-09-30 | -$2.42 10-Q · filed 2023-11-14 | -$0.18 10-Q · filed 2022-11-14 | -$4.91 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$7.61 10-Q · filed 2023-11-14 | -$0.57 10-Q · filed 2022-11-14 | -$2.71 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||
| 2022-06-30 | -$2.50 10-Q · filed 2023-08-14 | -$0.19 10-Q · filed 2022-08-11 | -$5.20 10-Q · filed 2023-08-14 | -$0.39 10-Q · filed 2022-08-11 | -$1.65 derived: net income ÷ weighted average shares · filed 2023-08-14 | -$1.53 derived: net income ÷ weighted average shares · filed 2023-08-14 | ||
| 2022-03-31 | -$2.71 10-Q · filed 2023-05-12 | -$0.20 10-Q · filed 2022-05-12 | -$0.80 derived: net income ÷ weighted average shares · filed 2023-05-12 | -$0.90 derived: net income ÷ weighted average shares · filed 2023-05-12 | -$1.02 derived: net income ÷ weighted average shares · filed 2023-05-12 | |||
| 2021-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.40 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.57 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.76 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$0.19 10-Q · filed 2022-11-14 | -$0.35 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.54 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | -$0.16 10-Q · filed 2022-08-11 | -$0.35 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | -$0.19 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |